Work

Supplementary Table Set S25-S29 from Comprehensive Genomic Analysis Identifies Novel Subtypes and Targets of Triple-Negative Breast Cancer

Year: 2023

Type: supplementary-materials

Abstract: Table S25. Subtype 1 (LAR) Pathways with Differentially Expressed Members in Either the Discovery, Validation, or External Sets Table S26. Subtype 2 (MES) Pathways with Differentially Expressed Members in Either the Discovery, Validation, or External Sets Table S27. Subtype 3 (BLIS) Pathways with Differentially Expressed Members in Either the Discovery, Validation, or External Sets Table S28. Subtype 4 (BLIA) Pathways with Differentially Expressed Members in Either the Discovery, Validation, or External Sets Table S29. Pathway Overlap Between Sets by Subtypes.

DOI: 10.1158/1078-0432.22460246

Authors: Matthew D. Burstein, Anna Tsimelzon, Graham M. Poage, Kyle R. Covington, Alejandro Contreras, Suzanne A.W. Fuqua, Michelle I Savage, C. Kent Osborne, Susan G. Hilsenbeck, Jenny C. Chang, Gordon B. Mills, Ching C. Lau, Powel H. Brown

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361919273

Cites:

Cited by:

Related to: 10